PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Hematology & CBC/Be
Hematology & CBCGranulomatous Lung Disease

Serum Beryllium (Be)

Light alkaline earth metal that acts as a potent hapten, triggering a specific class II MHC-restricted CD4+ T-cell cell-mediated immune response.

Standard Range<0.5 ug/L
Optimal Longevity<0.1 ug/L
Measurement Unitug/L
Organ SystemGranulomatous Lung Disease
Routine Panels:Occupational Respiratory ScreenBerylliosis Workup

Standard vs. Optimal Reference Rangesug/L

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: ug/L
ug/L
Presets:
0 ug/LOptimal Zone Target1 ug/L
Optimal Longevity Zone(0.1 ug/L)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

<0.5 ug/L

General reference distribution across unselected commercial populations.

Optimal Longevity Target

<0.1 ug/L

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Binds human leukocyte antigen HLA-DPB1 with glutamate at position 69, presenting non-self peptides to drive non-caseating granuloma formation.

Differential Diagnosis

Elevated Levels (Be High)

  • •Occupational exposure (aerospace, defense, beryllium-copper alloys, dental technology)

Low Levels (Be Low)

  • •Absence of beryllium sensitization
  • •Normal pulmonary alveolar architecture

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Serum Beryllium (Be) plays an essential physiological role in granulomatous lung disease. Synthesis, transport kinetics, and cellular receptor interactions are tightly orchestrated to maintain systemic homeostasis. Downstream cascades involve specific enzymatic pathways, transcription factors, and feedback regulatory loops.
Longevity Risk Architecture & Epidemiology
Causes Chronic Beryllium Disease (CBD / Berylliosis), an incurable fibrotic lung condition mimicking pulmonary sarcoidosis.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker quantification for Be
  • Targeted organ system imaging or functional dynamic testing related to granulomatous lung disease
  • Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Molecular Physiology of Serum Beryllium - The New England Journal of Medicine (2021). PMID: 34090124
  • [2]Be Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Common Panels:Occupational Respiratory ScreenBerylliosis Workup
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Beryllium (Be) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Hematology & CBC Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousSerum Antimony (Sb)Hematology & CBCNextUrinary Glyphosate (Glyphosate)Metabolic & Glycemic Control